IDXG首席执行官Thomas Burnell表示,随着交易的完成,公司的运营现金流预计每年将增加近500万美元,且将把出售所得用于满足营运资金需求,并用于投资发展分子诊断业务。
$药明康德(SH603259)$ $泰格医药(SZ...查看全文
不乱下2019-04-25 11:27
$Interpace诊断(IDXG)$ 从事于美国甲状腺癌/胰腺癌组织LDT基因诊断服务(不是液体活检),这是一家LDT服务商。 IDXG的主要产品都是并购过来的资产,所以这家公司的定位就是一个商业化公司而不是一个技术公司。 按照公司的说法,公司在甲状腺癌组织基因诊断服务方面技术上还是领先的,而胰腺癌好像...查看全文
$Interpace Diagnostics Group, Inc.(IDXG)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-23 AccNo: 0001493152-18-003786 Size: 8 MB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ 8-K - Current report Filed: 2018-03-15 AccNo: 0001493152-18-003418 Size: 162 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ 8-K - Current report Filed: 2018-03-13 AccNo: 0001493152-18-003293 Size: 33 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers...
$Interpace Diagnostics Group, Inc.(IDXG)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-08 AccNo: 0001535610-18-000027 Size: 13 KB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-13 AccNo: 0001493152-17-012822 Size: 5 MB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ D - Notice of Exempt Offering of Securities Filed: 2017-10-16 AccNo: 0001493152-17-011674 Size: 11 KB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ 8-K - Current report Filed: 2017-10-12 AccNo: 0001493152-17-011532 Size: 249 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ 8-K - Current report Filed: 2017-09-18 AccNo: 0001493152-17-010719 Size: 48 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-09-13 AccNo: 0001493152-17-010522 Size: 62 KB 网页链接
$Interpace Diagnostics Group, Inc.(IDXG)$ 8-K - Current report Filed: 2017-09-13 AccNo: 0001493152-17-010521 Size: 79 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers...